The relationship between hallucinations and FDG-PET in dementia with Lewy bodies

被引:27
|
作者
Firbank, Michael J. [1 ,2 ]
Lloyd, Jim [3 ]
O'Brien, John T. [4 ]
机构
[1] Newcastle Univ, Inst Neurosci, Campus Ageing & Vitality, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England
[2] Newcastle Univ, Inst Ageing, Campus Ageing & Vitality, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England
[3] Newcastle Upon Tyne Hosp NHS Fdn Trust, Nucl Med Dept, Newcastle Upon Tyne, Tyne & Wear, England
[4] Univ Cambridge, Sch Clin Med, Dept Psychiat, Box 189,Level E4,Cambridge Biomed Campus, Cambridge, England
基金
美国国家卫生研究院;
关键词
Visual hallucinations; DLB; FDG; Occipital lobe; VISUAL HALLUCINATIONS; ALZHEIMERS-DISEASE; BODY DEMENTIAS; DIAGNOSIS; DLB; METABOLISM; DONEPEZIL; CORTEX; SPECT; AD;
D O I
10.1007/s11682-015-9434-0
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Visual hallucinations are common in dementia with Lewy bodies (DLB), although their etiology is unclear. This study aimed to investigate the relationship between severity and frequency of hallucinations and regional brain glucose metabolism. We performed brain FDG-PET scanning on 28 subjects with DLB (mean age 76). The neuropsychiatric index (NPI) was used to assess frequency and severity of hallucinations. We used the SPM package to investigate voxelwise correlations between NPI hallucination score (severity x frequency) and FDG uptake relative to the cerebellum. There was a bilateral medial occipital region where reduced FDG was associated with increased hallucination severity and frequency. We conclude that the reduced occipital metabolism frequently seen in DLB is associated with frequency and severity of visual hallucinations. Further studies are required to investigate whether this is the result of deficits in top-down or bottom-up visual processing pathways.
引用
收藏
页码:636 / 639
页数:4
相关论文
共 50 条
  • [1] The relationship between hallucinations and FDG-PET in dementia with Lewy bodies
    Michael J. Firbank
    Jim Lloyd
    John T. O’Brien
    Brain Imaging and Behavior, 2016, 10 : 636 - 639
  • [2] Amygdala sign, a FDG-PET signature of dementia with Lewy Bodies
    Pillai, Jagan A.
    Wu, Guiyun
    Tousi, Babak
    Larvie, Mykol
    Leger, Gabriel C.
    Leverenz, James B.
    PARKINSONISM & RELATED DISORDERS, 2019, 64 : 300 - 303
  • [3] FDG-PET in suspected dementia with Lewy bodies: a case report
    Suantio, Astrid Melani
    Hian Liang Huang
    Kwok, Cecilia Sze Nga
    Teo, Darren Cheng Han
    Minh Ha Nguyen
    BMC GERIATRICS, 2019, 19 (1)
  • [4] FDG-PET in suspected dementia with Lewy bodies: a case report
    Astrid Melani Suantio
    Hian Liang Huang
    Cecilia Sze Nga Kwok
    Darren Cheng Han Teo
    Minh Ha Nguyen
    BMC Geriatrics, 19
  • [5] Metabolic network alterations in FDG-PET in prodromal Dementia with Lewy bodies
    Beyer, L.
    Stockbauer, A.
    Morbelli, S.
    Chincarini, A.
    Bruffaerts, R.
    Van Laere, K.
    Grmek, M.
    Garibotto, V.
    Nicastro, N.
    Frisoni, G. B.
    Lemstra, A. W.
    Pilotto, A.
    Garcia-Ptacek, S.
    Savitcheva, I.
    Ochoa-Figueroa, M. A.
    Davidsson, A.
    Camacho, V.
    Voeglein, J.
    Unterrainer, M.
    Pogarell, O.
    Bartenstein, P.
    Ewers, M.
    Aarsland, D.
    Nobili, F.
    Rominger, A.
    Brendel, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S439 - S440
  • [6] Comparison of FDG-PET and IMP-SPECT in patients with dementia with Lewy bodies
    Ishii, K
    Hosaka, K
    Mori, T
    Mori, E
    ANNALS OF NUCLEAR MEDICINE, 2004, 18 (05) : 447 - 451
  • [7] Comparison of FDG-PET and IMP-SPECT in patients with dementia with Lewy bodies
    Kazunari Ishii
    Kayo Hosaka
    Tetsuya Mori
    Etsuro Mori
    Annals of Nuclear Medicine, 2004, 18 : 447 - 451
  • [8] Differential alteration of neuronal network with FDG-PET in Alzheimer's disease and dementia with Lewy bodies
    Imai, Masamichi
    Tanaka, Mika
    Ishibashi, Kenji
    Wagatsuma, Kei
    Sakata, Muneyuki
    Toyohara, Jun
    Maruno, Hirotaka
    Ishii, Kenji
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [9] [18F]FDG-PET study in dementia with Lewy bodies and Alzheimer's disease
    Okamura, N
    Arai, H
    Higuchi, M
    Tashiro, M
    Matsui, T
    Hu, XS
    Takeda, A
    Itoh, M
    Sasaki, H
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2001, 25 (02): : 447 - 456
  • [10] The relationship between plasma biomarkers and amyloid PET in dementia with Lewy bodies
    Donaghy, Paul C.
    Firbank, Michael
    Petrides, George
    Lloyd, Jim
    Barnett, Nicola
    Olsen, Kirsty
    Heslegrave, Amanda
    Zetterberg, Henrik
    Thomas, Alan J.
    O'Brien, John T.
    PARKINSONISM & RELATED DISORDERS, 2022, 101 : 111 - 116